Joseph Eron, MD
Enriched profileChief, Division of Infectious Diseases; Herman and Louise Smith Distinguished Professor of Medicine · University of North Carolina at Chapel Hill
Joseph Eron is Chief, Division of Infectious Diseases; Herman and Louise Smith Distinguished Professor of Medicine at University of North Carolina at Chapel Hill. ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Joseph J. Eron, Jr., MD, is Chief, Division of Infectious Diseases at University of North Carolina at Chapel Hill, School of Medicine. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 8 companies, 9 NIH-funded awards (1995–2026).
- Top research focus: HIV
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Co-led NIH/ACTG congressional briefing on HIV treatment and prevention research
Dirksen Senate Office Building, Washington DC
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalhealth.unc.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
Updated 27 Aug 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202515 payments$17,830openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year20254 payments
- Shionogi IncProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
51.3%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor17.5%Tivicay57%Dovato15%Juluca11%Isentress10%Cabenuva8%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor10.9%Descovy100%Part D≥12 patientsNervous system
26.4%Opioid Agonist11.2%Oxycodone-Acetaminophen47%Oxycodone Hcl42%Morphine Sulfate Er11%Part D<11 patientsBenzodiazepine5.4%Alprazolam68%Clonazepam32%Part D<11 patientsCardiovascular
12.3%Statin7.3%Atorvastatin Calcium51%Rosuvastatin Calcium49%Part D<11 patientsThiazide diuretic3%Hydrochlorothiazide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
9 NIH research awards on record, funded 1995–2026 per NIH RePORTER. The latest:
- Leadership and Operations Center (LOC), AIDS Clinical Trials Group
Univ of North Carolina Chapel Hill
FY2026$31,952,118UM1AI068636 - University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
Univ of North Carolina Chapel Hill
FY2026$4,869,383UM1AI069423 - Leadership and Operations Center (LOC), AIDS Clinical Trials Group
Univ of North Carolina Chapel Hill
FY2026$755,409UM1AI068636
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 577. Week 48 Results of a Phase 2 Study Evaluating Once-weekly Oral Islatravir Plus Lenacapavir
Open Forum Infectious Diseases
2025 - P-430. Reason for Hospitalization Contrasting Adjudication versus ICD-10 Coding Among Persons with HIV, 2016-2019
Open Forum Infectious Diseases
2025 - Longitudinal monitoring of cabotegravir and rilpivirine exposure from hair strand concentrations
British Journal of Clinical Pharmacology
2025
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/joseph-eron-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Joseph-Eron-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/joseph_eron
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/unc-department-of-medicine_a-phase-2-study-led-by-dr-joe-eron-chief-activity-7424125776381321216-qSUZ
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Residency
Internal Medicine, Massachusetts General Hospital, Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Fellowship
Infectious Diseases, Massachusetts General Hospital, Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Undergraduate degree
Harpur College
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Editorial & leadership roles
journal and society appointments- Member
AIDS Clinical Trials Group (since 1993); former Chair, Optimization of ART Committee and Cure/HIV Reservoirs Transformative Science Group
1993verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Vice Chair (co-Principal Investigator)
AIDS Clinical Trials Group (ACTG) / Advancing Clinical Therapeutics Globally
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Leader
ACTG Scientific Agenda Steering Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Professor of Epidemiology
UNC Gillings School of Global Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sph.unc.edu ↗ - Director
Clinical Core, UNC Center for AIDS Research (CFAR)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Faculty
UNC Institute for Global Health and Infectious Diseases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalhealth.unc.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →croiconference.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill